Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05038566 · ClinicalTrials.gov registry record · NA
Dexterous Partial Hand Prosthesis Outcomes
A NA study, sponsored by Liberating Technologies.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05038566: Completed NA study, sponsored by Liberating Technologies.
NCT05038566 is a NA study that has completed, run by Liberating Technologies. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05038566, a NA study, has completed, sponsored by Liberating Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Liberating Technologies, Inc. (LTI) has developed a dexterous prosthetic fingertip that will be fit onto an i-Digits™ partial hand prosthesis and allow for an additional fine grasp. The device will interface with research participants' existing prostheses and use the same control strategy that is used for their everyday use. Each participant's prosthesis will be restored to their original configuration by the end of their testing period.
Primary Outcome
During the in-lab portion of the study, subjects will be asked to complete the 'small common objects' subtask of the Jebsen-Taylor Hand Function Test, which assesses a broad range of unimanual hand functions required for ADLs. The primary quantitative measure of the Jebsen-Taylor task will be completion time of each subtask. The maximum time allotted for each task was 120 seconds, at which point the subject was told to stop the task and the time was reported as the maximum 120 seconds. This test
Interventions
- DEVICE Pointdexter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2022-04-28 |
| Phase | NA |
What the finished NCT05038566 record still lists
NCT05038566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Pointdexter is the first listed.
NCT05038566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05038566 about?
NCT05038566 is a clinical study titled "Dexterous Partial Hand Prosthesis Outcomes". Liberating Technologies, Inc. (LTI) has developed a dexterous prosthetic fingertip that will be fit onto an i-Digits™ partial hand prosthesis and allow for an additional fine grasp. The device will interface with research participants' existing prostheses and use the same control strategy that is us...
What is the current status of trial NCT05038566?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2021-07-15. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT05038566?
The interventions under investigation include: Pointdexter (DEVICE).
Who is sponsoring clinical trial NCT05038566?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05038566's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI